X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/03/2856873/0/en/Apnimed-to-Participate-in-the-23rd-Annual-Needham-Virtual-Healthcare-Conference.html
https://www.globenewswire.com//news-release/2024/03/06/2841350/0/en/Apnimed-to-Participate-in-the-Upcoming-Leerink-Partners-Global-Biopharma-Conference.html
https://www.globenewswire.com//news-release/2024/02/22/2833639/0/en/Apnimed-to-Participate-in-the-Upcoming-Evercore-ISI-2024-Emerging-Biotech-Conference.html
https://endpts.com/apnimed-a-late-stage-sleep-apnea-biotech-eyes-ipo-in-the-second-half/
https://endpts.com/apnimed-hires-pfizer-biohaven-veteran-as-chief-commercial-officer/
https://www.globenewswire.com//news-release/2024/01/22/2812888/0/en/Apnimed-Announces-New-Leadership-Appointments-as-the-Company-Builds-Its-Commercial-and-Human-Resource-Capabilities-in-Support-of-AD109-a-Potential-Nighttime-Oral-Treatment-for-Obst.html
https://www.globenewswire.com//news-release/2023/12/21/2799991/0/en/Apnimed-Announces-First-Patient-Dosed-in-SynAIRgy-the-Second-Phase-3-Clinical-Study-of-AD109-a-Potential-Nighttime-Oral-Treatment-for-Obstructive-Sleep-Apnea.html
https://www.globenewswire.com//news-release/2023/11/06/2774026/0/en/Apnimed-to-Participate-in-Upcoming-November-Investor-Conferences.html
https://www.globenewswire.com//news-release/2023/11/01/2770728/0/en/Apnimed-Announces-Launch-of-Joint-Venture-with-Shionogi-to-Develop-Novel-Pharmacologic-Therapies-for-Obstructive-Sleep-Apnea-and-other-Sleep-Disorders.html
https://www.globenewswire.com//news-release/2023/10/18/2762294/0/en/Apnimed-to-Present-Review-of-Recent-Data-on-Investigational-Pharmacologic-Treatment-for-Obstructive-Sleep-Apnea-at-World-Sleep-2023.html
Market Place
Share 
